NCT04526405View on ClinicalTrials.gov

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

November 3, 2020

Study Completion Date

November 3, 2020

Conditions
Thalassemia MajorCovid19
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 S1/S2 IgG

SARS-CoV-2 S1/S2 IgG analysis

Trial Locations (1)

20900

ASST Monza - Ospedale San Gerardo, Monza

All Listed Sponsors
lead

University of Milano Bicocca

OTHER

NCT04526405 - Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases | Biotech Hunter | Biotech Hunter